Knee osteoarthritis, a progressive and painful condition, has long been managed through a combination of lifestyle ...

The results of a clinical trial published this week found that the active ingredient in the diabetes and weight loss medications Ozempic and Wegovy was linked with a near halving of reported pain ...

A large trial showed that semaglutide, sold as Ozempic for diabetes and as Wegovy for obesity, was better than any current ...

In a groundbreaking new study, Ozempic was found to be so effective at treating arthritis that people no longer needed ...

Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to traditional pharmacological interventions.

Semaglutide (Wegovy) reduced pain and improved physical function in patients with obesity and knee osteoarthritis, a ...

Treatment with other antiobesity medications was not permitted; the use of other interventions for knee osteoarthritis was permitted. Although pain medication could be used throughout the trial ...

Total hip replacement is routinely recommended for severe hip osteoarthritis, but data from randomized trials are lacking ...

Subcutaneous semaglutide is currently marketed under the brand name Wegovy for chronic weight management and to reduce the risk of major adverse cardiovascular events in adults with established ...

The National Institutes of Health has awarded a five-year, $2.79 million grant to Shuying Yang and Michael Mitchell for their ...

New research shows that blood-based immunophenotyping can enhance rheumatoid arthritis treatment by identifying immune ...

Osteoarthritis, the most common form of arthritis, is primarily caused by wear and tear on the protective layer of cartilage ...